1 / 24

Plenary Meeting of the Sector Social Dialogue Committee of the European Chemical Industry

Plenary Meeting of the Sector Social Dialogue Committee of the European Chemical Industry. Situation of the pharmaceutical sector in Germany Dr. Paul K riegelsteiner Verband der Chemischen Industrie – Landesverband Nordost - Dublin 2013, April 9th.

yoshi
Download Presentation

Plenary Meeting of the Sector Social Dialogue Committee of the European Chemical Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Plenary Meetingof the Sector Social Dialogue Committee of the European Chemical Industry Situation of the pharmaceutical sector in Germany Dr. Paul Kriegelsteiner Verband der ChemischenIndustrie – LandesverbandNordost - Dublin2013, April 9th

  2. Whatdo German gummibearshaveto do withpainkillers? – Wait a moment…

  3. Pharmaceutical industry helps you to live longer…

  4. Pharmaceutical industry for a longer life Survivalrates on cancer (in percentwithinfiveyears)

  5. Pharmaceutical industry for a longer life

  6. Pharmaceutical industry for a longer life

  7. German pharmaceuticalindustry

  8. German pharmaceuticalindustry

  9. German pharmaceuticalindustry

  10. Berlin: still and againGermany‘s „Pharmahauptstadt“ pharmaceuticalcapital www. pharmahauptstadt.de

  11. Pharmaceutical industry – highest added value … why do politicianslovecarmanufacturers and whywouldtheybashthepharmaceuticalindustry?

  12. Production on therighttrack… „… crisis? Whatcrisis?“

  13. … but not for theGerman market!

  14. Prices underpressure … and whoissupposedtopay for highercosts on raw materials, energy and – staff?

  15. The statededucts a discount …

  16. Low pricelevel in germany formsreferenceprice for manyeuropean countries

  17. Discounts bylaw on ANY level

  18. Changes in competitiveconditionsofthepharmaceuticalindustry

  19. Pharmaceutical industry: Strategic innovators with regulatory obstacles IW survey on "Germany's future industries”: “Germanys legal and political framework jeopardizes the pharmaceutical industry, which is otherwise extremely sustainable. This expert vote should be taken as a warning by the politicians," Hüther said in commenting the results.

  20. … or in our own words: • Every politician would be wise to promote the pharmaceutical industry of his country and keep it prosperous: • Future industry • High standards of research and development • Good jobs with high incomes (and taxes) • Security for the home market • What is the idea behind pharma bashing and turning us into scape goats?

  21. sells in your GERMAN pharmacy for: 12,29.- € minus VAT 19% 1,96 € Pharmacy Add-on „Apothekenzuschlag“ 8,35 € plus 3% 8,60 € WholeSale Add-on „Großhandelszuschlag“ 3,15% plus fix 0,70 € 0,73 € Manufacturer1,00 €

  22. Nowyouknow: somemedicationearnslessthan a bagofgummibears!

  23. … pleaseacceptmy personal advice: When in Germany: youbetterstayhealthy!

  24. Thank you for your attention! Dr.Paul Kriegelsteiner European Chemical Employers Group (ECEG) Verband der chemischenIndustrie LandesverbandNordost www.nordostchemie.de kriegelsteiner@nordostchemie.de +49 30 34381610

More Related